Jakavi 10 mg tablets, Jakavi 10 mg tablets, Jakavi 20 mg tablets, Jakavi 5 mg tablets, elritercept, Jakavi 20 mg tablets, Jakavi 20 mg tablets, Jakavi 10 mg tablets, Jakavi 5 mg tablets, Jakavi 5 mg tablets
KER050-MF-301
Phase 2 small_molecule active
Quick answer
Jakavi 10 mg tablets, Jakavi 10 mg tablets, Jakavi 20 mg tablets, Jakavi 5 mg tablets, elritercept, Jakavi 20 mg tablets, Jakavi 20 mg tablets, Jakavi 10 mg tablets, Jakavi 5 mg tablets, Jakavi 5 mg tablets for Myelofibrosis is a Phase 2 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Myelofibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active